In 2014, the GLS inhibitor CB-839, undergoing clinical trials, was reported to possess potent anti-tumor activity, offering a novel avenue for targeted cancer therapy through modulation of glutamine metabolism [14]
When the body produces too many free radicals, it can cause oxidative stress unwanted cellular reactions which negatively impact the body and its cells
28.0 28.1 28.2 Shields JA, Shields CL
Interestingly, PLC offers some potentially advantageous properties over LC such as the ability to replenish intermediates of the TCA by the propionyl-CoA moiety
There was a marginal reduction in plasma GH response after a provocative i.v
In some embodiments, the otic formulation or composition comprises about 0.4% by weight of the cholesterol